Clinical trial
A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical…
NCT00134264 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00134264 |
|---|---|
| Title | A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease |
| Official title | Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjects With Coronary Heart Disease Or Risk… |
| Acronym | ILLUMINATE |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Disease, Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, atorvastatin |
| Enrollment | 15,067 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Aug 24, 2005 |
| Last update posted | Feb 3, 2012 |
| Countries | Australia, Canada, Netherlands, Spain, Sweden, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: